UK MHRA Approves New Oral Treatment for Plaque Psoriasis
The UK MHRA has approved a new oral treatment for moderate to severe plaque psoriasis, offering an additional therapeutic option for patients in the UK.
Icotrokinra Hydrochloride UK MHRA Approval | 26/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy